Reactivation of rheumatoid arthritis during continuous infusion of interleukin 2: evidence of lymphocytic control of rheumatoid disease.
Lavelle-Jones
M
M
Ninewells Hospital and Medical School, Dundee.
al-Hadrani
A
A
Spiers
E M
EM
Campbell
F C
FC
Cuschieri
A
A
D001172:Arthritis, Rheumatoid / Q000097:blood / Q000209:etiology*; D002277:Carcinoma / Q000097:blood / Q000556:secondary* / Q000628:therapy; D015179:Colorectal Neoplasms / Q000097:blood / Q000628:therapy*; D005260:Female; D006801:Humans; D007376:Interleukin-2 / Q000009:adverse effects*; D007958:Leukocyte Count; D008214:Lymphocytes; D008875:Middle Aged; D011994:Recombinant Proteins / Q000009:adverse effects; D012008:Recurrence
D007376:Interleukin-2; D011994:Recombinant Proteins